A study investigating effect of interpatient variability on platelet reactivity in patients treated with Prasugrel and ticagrelor.
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2016
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Abdominal aortic aneurysm; Acute coronary syndromes; Cardiovascular disorders; Coronary artery disease; Sickle cell anaemia; Stroke
- Focus Pharmacodynamics